# nanoTherics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanotherics

- Industry: Biotechnology
- Headquarters: Newcastle-under-Lyme, UK
- Website: www.nanotherics.com
- Total disclosed funding: $1.9M
- Latest round: Series B (Aug 27, 2010)
- Investors on record: 2

## About

nanoTherics, Ltd. develops advanced magnetic hyperthermia equipment, focusing on innovative solutions for research and healthcare applications. Their flagship magneTherm system allows versatile operations in magnetic nanoparticle heating and drug delivery.Founded in 2007 and headquartered in Newcastle under Lyme, UK, nanoTherics, Ltd. is dedicated to creating state-of-the-art magnetic hyperthermia technologies. The company has raised GBP 262,000 in venture funding as of January 6, 2016, which has been pivotal for its growth, valuing the company at GBP 2.08 million. The CEO, Carl Jones, has been instrumental in navigating the company's strategies and expansion efforts across multiple global markets.nanoTherics Ltd specializes in developing and providing advanced magnetic hyperthermia equipment, with a focus on their flagship product, the magneTherm system. This platform supports multiple applications, including calorimetric studies, in vitro and in vivo research, and drug delivery systems. The magneTherm system is customizable according to user specifications and serves clients globally, including leading academic institutions and healthcare providers across North America, Europe, Asia, and Australia.The revenue model of nanoTherics primarily revolves around the sale of its magneTherm systems and associated accessories to institutional clients, including universities and research facilities. These transactions often align with grant funding for scientific research. While specific pricing details are undisclosed, the product range incorporates customizable options and upgrades, fostering long-term relationships through ongoing support and ancillary consumables. The successful integration of the magneTherm system into diverse applications is evidenced by sales across 27 countries, reinforcing its position in the magnetic hyperthermia sector.In January 2016, nanoTherics, Ltd. raised GBP 262,000 in venture funding, which will be utilized to further develop its product offerings and expand into new geographic markets. The company aims to enhance its product lineup and is focusing on specific regions, including North America and Asia, for market expansion. This funding round has positioned nanoTherics for strategic growth, leveraging its recent innovations and broadening its client base.

## Funding rounds

- Series B, Aug 27, 2010, $1.9M — Catapult Ventures Group, Mercia Fund Management

## Investors

- Catapult Ventures Group (https://capitalatlas.ai/funds/catapult-ventures-group) — Series B
- Mercia Fund Management — Series B